Natural Products
| Catalog No. | Information |
| CFN95096 | 1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside Reference standards. |
| CFN95097 | Physalin O Physalin O possesses anti-inflammatory activity, it exhibited conjugating abilities with GSH and also showed significant nitric oxide (NO) production inhibiting activities. |
| CFN95098 | 2-Cinnamoyl-1-galloylglucose Reference standards. |
| CFN95099 | Oleuroside Reference standards. |
| CFN95100 | 1,4-Dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-beta-glucopyranoside 1,4-Dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-beta-glucopyranoside may have DNA topoisomerases I and II inhibitory activity and cytotoxicity. |
| CFN95101 | 1-Methyl-2,8-dihydroxy-3-carboxy-9,10-anthraquinone Reference standards. |
| CFN95102 | 3'-Hydroxymirificin Reference standards. |
| CFN95103 | Cyclocurcumin Cyclocurcumin, a curcumin derivative, exhibits anticancer, anti-inflammatory, and immune-modulating abilities and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method. It may have a therapeutic potential as a novel antivasoconstrictive natural product. Cyclocurcumin offers higher neuronal protection than curcumin, they both reduced the level of ROS caused by MPP+ treatment. |
| CFN95104 | Physalin G Physalin G has antinociceptive property. |
| CFN95105 | 6-O-(E)-Caffeoylglucopyranose Reference standards. |
| CFN93694 | Irilone Irilone has immunomodulatory, and α-amylase inhibitory activities, it exhibits the selective inhibition toward CYP3 A4 rather than other major human CYPs. Irilone exhibited prominent antioxidant activities with the IC50 value of 10.46μM. Irilone potentiated the effect of progesterone in both endometrial and ovarian cancer cell lines, it protected dopaminergic neurons against LPS-induced injury through inhibition of microglia activation and proinflammatory factors generation. |
| CFN93556 | Luteolin 7-rutinoside Luteolin 7-rutinoside has antiallergic, antimicrobial, antimutagenic and radical scavenging activities, it showed antimutagenic effects on TA1537 and TA1535 strains. Luteolin 7-rutinoside also displayed potent rat lens aldose reductase inhibitory activities with IC(50) values ranging from 0.19 to 5.37 μM. |
| CFN93557 | Xanthoangelol B Xanthoangelol B and its derivative PM-56 were shown to bind directly to SaeS and inhibit its histidine kinase activity, which suggests a possibility of a broad spectrum inhibitor of histidine kinases. Xanthoangelol B inhibited the phenylephrine-induced vasoconstriction most strongly, and the inhibitory mechanism of it on phenylephrine-induced vasoconstriction might involve the direct inhibition of smooth muscle functions through the reduction of [Ca2+]i elevation without affecting EDRF/NO production. |
| CFN93579 | Xanthoangelol Xanthoangelol has anti-inflammatory,anti-platelet and antibacterial activities. It also shows antitumor and/or antimetastatic activities, which may be due to inhibition of DNA synthesis in LLC cells and of tumor-induced neovascularization through inhibition of the formation of capillary-like tubes by vascular endothelial cells and inhibition of the binding of VEGF to vascular endothelial cells. Xanthoangelol may be applicable as an effective drug for treatment of neuroblastoma and leukemia. |
| CFN93664 | Xanthoangelol F Xanthoangelol F showed strong PTP1B inhibitory effect with the IC50 values of 1.67 μg/mL. It inhibited phenylephrine-induced vasoconstriction through endothelium-dependent production of EDRF/NO and/or through the reduction of the [Ca2+]i elevation induced by phenylephrine. |
| CFN93712 | 3,5-di-O-caffeoylquinic acid 3,5-di-O-caffeoylquinic acid as a neuraminidase inhibitory ligand in Flos Lonicerae, it has neuroprotective effects on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1. 3,5-di-O-caffeoylquinic acid also has antioxidant and anti-complementary activities. |
| CFN95561 | Methyl caffeate acid Methyl caffeate acid shows anti-complementary activity. |
| CFN93777 | Secologanoside Secologanoside shows anti-complementary, allelopathic, and anti-elastase activities. |
| CFN93776 | Luteolin-4'-O-glucoside Luteolin 4'-O-glucoside as a IL-5 inhibitor, it has anti-complementary,and anti-oxdiant activities. |
| CFN93558 | Luteolin-3',7-di-O-glucoside Luteolin-3',7-di-O-glucoside has anti-ulcer and antioxidant activities. |
| CFN95106 | Isololiolide Isololiolide has phytotoxicity, it inhibited seedling growth of cress and barnyard grass. It also showed in vitro activity against both trypomastigote and intracellular amastigotes of Trypanosoma cruzi, with IC50 values of 32 μM and 40 μM, respectively. Isololiolide is an antioxidant response element (ARE) inducer, it has anti-inflammatory activity. It can exert a selective cytotoxic activity on hepatocarcinoma HepG2 cells as well as induce apoptosis through the modulation of apoptosis-related proteins. |
| CFN95107 | Tuberosin Tuberosin shows anti-inflammatory and antioxidant activities.It demonstrated a significantly potent inhibition on yeast α-glucosidase in a dose dependent manner. |
| CFN95108 | Tangshenoside I Tangshenoside I might be a potential bioactive marker related to the hematopoietic and immunologic functions of Codonopsis Radix, which could be recommended as the index compound. It has α-glucosidase inhibition activity. |
| CFN95109 | Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity. |
| CFN95110 | Pilosidine Pilosidine has vasoconstrictor activity, it showed facilitating effect on adrenaline evoked contractions in rabbit aorta isolated preparations. |
| CFN95111 | 2-O-cinnamoyl-beta-D-glucose Reference standards. |
| CFN95112 | 3'-Methoxymirificin Reference standards. |
| CFN95113 | Macrophylloside D Reference standards. |
| CFN95114 | 1-Isomangostin 1-Isomangostin has cytotoxic, and anticomplement activities. |
| CFN95115 | Hamaudol Hamaudol has analgesic and anti-inflammary activities, it showed inhibitory activity on COX-1 and COX-2 activities with values of 0.30, 0.57 mM, respectively. |
| CFN95116 | Rhamnetin 3-galactoside Reference standards. |
| CFN95117 | Polygalasaponin XLIX Reference standards. |
| CFN91060 | Niga-ichigoside F1 Niga-ichigoside F1(NI) has anti-inflammatory, gastroprotective ,antinociceptive, and cytotoxic effects. NI showed an inhibition zone on β-glucosidase and anti-acetylcholinesterase assays. The dietary NI could prevent HFD-induced hepatic steatosis, possibly via interacting with HFD to activate Nrf2 nuclear translocation to maintain a redox status, thus regulating lipid metabolism genes expressions. |
| CFN91061 | Celosin I Celosin H, celosin I, and celosin J could be used as chemical markers for the quality control of C. argentea seeds. Celosin I exhibited significant hepatoprotective effect on carbon tetrachloride-induced and N,N-dimethylformamide-induced hepatotoxicity in mice. |
| CFN91062 | Cyclo(Hyp-Val) Reference standards. |
| CFN91063 | Osmundacetone Reference standards. |
| CFN91064 | Quercetin 3-O-(6''-galloyl)-beta-D-glucopyranoside Reference standards. |
| CFN91065 | Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside can effectively induce apoptosis via p53, MAPKs and the mitochondrial apoptotic pathways. |
| CFN91066 | Zerumbone Zerumbone is a potential antimicrobial and antibiofilm agent indicated for the therapeutic management of nosocomial medical device-related infections induced by dual-species biofilms of C. albicans and S. aureus. Zerumbone protects the neuronal injury and ameliorates the cognitive function by stimulating the proliferation of endogenous neural stem cells; it suppresses enterotoxigenic bacteroides fragilis infection-induced colonic inflammation through inhibition of NF-κΒ. Zerumbone exhibits a hepatoprotective effect against ALI through its antioxidant and anti-inflammatory activities and the possible mechanism might be mediated by the TLR4/NF-κB/COX-2 pathway. Zerumbone can be a potential candidate for development of immunosuppressive agent. |
| CFN91067 | Suavissimoside F1 Reference standards. |
| CFN91068 | Soyasapogenol C Reference standards. |
| CFN91069 | Soyasapogenol D Reference standards. |
| CFN91070 | Isosilybin A Isosilybin A is a partial PPARγ agonist, it significantly induced ABCA1 protein expression, it inhibited both monophenolase (IC50 = 1.7-7.6 µM) and diphenolase (IC50 = 12.1-44.9 µM) of tyrosinase. Isosilybin A shows anti-angiogenic efficacy, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. |
| CFN91071 | Isosilybin B Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. Isosilybin B showed inhibitory effect on CYP2C8 activity. It inhibited both monophenolase (IC50 = 1.7-7.6 μM) and diphenolase (IC50 = 12.1-44.9 μM) of tyrosinase. |
| CFN91072 | 19 alpha-Hydroxyasiatic acid 19 alpha-Hydroxyasiatic acid shows significant anticoagulant effect on the extrinsic pathway. |
| CFN95118 | Polygalin C Reference standards. |
| CFN91073 | Betulinic acid methyl ester Betulinic acid methyl ester showed antiplasmodial activity against chloroquine-resistant Plasmodium falciparum parasites in vitro.It also inhibited B16 2F2 cell proliferation by induction of apoptosis. |
| CFN95119 | Isorubrofusarin 10-gentiobioside Isorubrofusarin 10-gentiobioside shows promising inhibitory activity against AChE/BACE1. |
| CFN95120 | Cassiaside C Reference standards. |
| CFN95121 | Cistantubuloside C1 Reference standards. |
